Seong Lin Khaw
Royal Children's Hospital(AU)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, CAR-T cell therapy research
Most-Cited Works
- → ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets(2013)2,976 cited
- → Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease(2011)811 cited
- → Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer(2020)387 cited
- → Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial(2022)326 cited
- → Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma(2021)275 cited
- → Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells(2012)190 cited
- → VDAC2 enables BAX to mediate apoptosis and limit tumor development(2018)182 cited
- Souers AJ, Leverson JD, Boghaert ER et al.ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med 19:202-208(2013)
- → Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia(2016)170 cited
- → Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1(2016)142 cited